CompletedNot Applicable

Intensive Insulin Therapy as Therapeutic Strategy for Non-diabetic Hyperglycemia After Surgery in ICU

Saudi Arabia86 participantsStarted 2017-09-14

Plain-language summary

The current study hypothesizes that the use of Intravenous intensive insulin therapy (IV-IIT) may be beneficial than IV conventional insulin therapy (IV-CIT) for improving the outcome of non-diabetic surgical patients had postoperative (PO) stress hyperglycemia (PSH).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All postoperative patients who will be admitted to surgical ICU and developed Post Surgical Hyperglycemia will be eligible for evaluation for inclusion and exclusion criteria Exclusion Criteria: * All patients having diabetes mellitus, history of preoperative stress hyperglycemia, endocrinopathies, obesity defined as body mass index (BMI) \>30 kg/m2, age younger than 18 years, renal impairment or maintenance on renal replacement therapy and liver diseases.

What they're measuring

The number of IV-Insulin Therapy sessions required till stabilization of the targeted Blood Glucose level.

Timeframe: 180 days

Trial details

NCT IDNCT04554615

SponsorTanta University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-03-03

View on ClinicalTrials.gov More Hyperglycemia trials